Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the Company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.

The new facilities accommodate recent hires to Sphere Fluidics’ commercial and leadership team, as well as preparing for further recruitment by the end of the year. The first phase of building has opened 7,000 sq ft of space and has been purpose built with state-of-the-art equipment, including a demonstration lab to give customers the opportunity to see the Company’s single cell analysis and monoclonality assurance systems at work. The second phase, due to complete by the end of the 2023, will expand the Company’s footprint further to around 30,000 sq ft.

Granta Park is one of the UK’s leading life-science research parks and a world-renowned centre of excellence spanning over 120 acres of land. Custom designed and renovated by COEL, Sphere Fluidics’ new laboratories are in addition to offices at Babraham Research Campus, also in Cambridgeshire (UK). The Company also has an established network of international distributors in Japan, France, China, Switzerland, Germany, Austria, Benelux, Australia, Scandinavia, Korea and the USA.

Dr Frank F Craig, CEO, Sphere Fluidics, commentedWe are on an exciting growth trajectory – this state-of-the-art site at Granta Park gives us another opportunity to attract new talent to our team, and continue our rapid expansion. With the first stage of building complete, we look forward to harnessing the space to encourage customer visits and sales and develop new products for our customers.”

Rob Treanor, Director of Operations, Sphere Fluidics, added “It is important that our scientific and commercial teams are provided with the very best environment to work, and with our new world-class facilities, we are proud to be able to offer this within one of the UK’s most prestigious science parks. We hope to have the entire UK workforce under one roof by the end of next year, as we continue to develop the business.”

For more information about Sphere Fluidics, please visit: https://spherefluidics.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sphere Fluidics Limited. (2023, April 03). Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK. AZoLifeSciences. Retrieved on November 24, 2024 from https://www.azolifesciences.com/news/20221025/Sphere-Fluidics-opens-new-laboratory-facilities-at-Granta-Park-in-Cambridgeshire-UK.aspx.

  • MLA

    Sphere Fluidics Limited. "Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK". AZoLifeSciences. 24 November 2024. <https://www.azolifesciences.com/news/20221025/Sphere-Fluidics-opens-new-laboratory-facilities-at-Granta-Park-in-Cambridgeshire-UK.aspx>.

  • Chicago

    Sphere Fluidics Limited. "Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK". AZoLifeSciences. https://www.azolifesciences.com/news/20221025/Sphere-Fluidics-opens-new-laboratory-facilities-at-Granta-Park-in-Cambridgeshire-UK.aspx. (accessed November 24, 2024).

  • Harvard

    Sphere Fluidics Limited. 2023. Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK. AZoLifeSciences, viewed 24 November 2024, https://www.azolifesciences.com/news/20221025/Sphere-Fluidics-opens-new-laboratory-facilities-at-Granta-Park-in-Cambridgeshire-UK.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.